+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

From
From
Basal Cell Carcinoma Treatment Market Report 2026 - Product Thumbnail Image

Basal Cell Carcinoma Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Cystic Fibrosis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Cystic Fibrosis Therapeutics - Global Strategic Business Report

  • Report
  • August 2026
  • 282 Pages
  • Global
From
From
Stem Cell Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Stem Cell Therapy Market - Global Forecast 2026-2032

  • Report
  • August 2026
  • 192 Pages
  • Global
From
From
From
From
From
Multiple Myeloma Drugs Market Report 2026 - Product Thumbnail Image

Multiple Myeloma Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2026

  • Report
  • April 2026
  • 500 Pages +
  • Global
From
Leukemia Therapeutics Market Report 2026 - Product Thumbnail Image

Leukemia Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
From
Halothane Market - Global Forecast to 2030 - Product Thumbnail Image

Halothane Market - Global Forecast to 2030

  • Report
  • August 2025
  • 183 Pages
  • Global
From
Loading Indicator